207 related articles for article (PubMed ID: 22121872)
1. Epigenetic targets in human neoplasms.
Fandy TE; Gore SD
Epigenomics; 2010 Apr; 2(2):221-32. PubMed ID: 22121872
[TBL] [Abstract][Full Text] [Related]
2. Consolidation of the cancer genome into domains of repressive chromatin by long-range epigenetic silencing (LRES) reduces transcriptional plasticity.
Coolen MW; Stirzaker C; Song JZ; Statham AL; Kassir Z; Moreno CS; Young AN; Varma V; Speed TP; Cowley M; Lacaze P; Kaplan W; Robinson MD; Clark SJ
Nat Cell Biol; 2010 Mar; 12(3):235-46. PubMed ID: 20173741
[TBL] [Abstract][Full Text] [Related]
3. Re-expression of methylation-induced tumor suppressor gene silencing is associated with the state of histone modification in gastric cancer cell lines.
Meng CF; Zhu XJ; Peng G; Dai DQ
World J Gastroenterol; 2007 Dec; 13(46):6166-71. PubMed ID: 18069755
[TBL] [Abstract][Full Text] [Related]
4. Epigenetics in cancer.
Esteller M
N Engl J Med; 2008 Mar; 358(11):1148-59. PubMed ID: 18337604
[No Abstract] [Full Text] [Related]
5. Transcriptional silencing of the TMS1/ASC tumour suppressor gene by an epigenetic mechanism in hepatocellular carcinoma cells.
Zhang C; Li H; Zhou G; Zhang Q; Zhang T; Li J; Zhang J; Hou J; Liew CT; Yin D
J Pathol; 2007 Jun; 212(2):134-42. PubMed ID: 17471463
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic analysis in the search for tumor suppressor genes.
Han ZG
Epigenomics; 2010 Aug; 2(4):489-93. PubMed ID: 22121966
[No Abstract] [Full Text] [Related]
7. Remodeling epigenetic modifications at tumor suppressor gene promoters with bovine oocyte extract.
Wang Z; Yue Y; Han P; Sa R; Ren X; Wang J; Bai H; Yu H
Cytotherapy; 2013 Sep; 15(9):1164-73. PubMed ID: 23800731
[TBL] [Abstract][Full Text] [Related]
8. The epigenetics of oral cancer.
Shaw R
Int J Oral Maxillofac Surg; 2006 Feb; 35(2):101-8. PubMed ID: 16154320
[TBL] [Abstract][Full Text] [Related]
9. Histone methylation-mediated silencing of miR-139 enhances invasion of non-small-cell lung cancer.
Watanabe K; Amano Y; Ishikawa R; Sunohara M; Kage H; Ichinose J; Sano A; Nakajima J; Fukayama M; Yatomi Y; Nagase T; Ohishi N; Takai D
Cancer Med; 2015 Oct; 4(10):1573-82. PubMed ID: 26256448
[TBL] [Abstract][Full Text] [Related]
10. Interplay between microRNAs and the epigenetic machinery: an intricate network.
Iorio MV; Piovan C; Croce CM
Biochim Biophys Acta; 2010; 1799(10-12):694-701. PubMed ID: 20493980
[TBL] [Abstract][Full Text] [Related]
11. Dominant-negative histone H3 lysine 27 mutant derepresses silenced tumor suppressor genes and reverses the drug-resistant phenotype in cancer cells.
Abbosh PH; Montgomery JS; Starkey JA; Novotny M; Zuhowski EG; Egorin MJ; Moseman AP; Golas A; Brannon KM; Balch C; Huang TH; Nephew KP
Cancer Res; 2006 Jun; 66(11):5582-91. PubMed ID: 16740693
[TBL] [Abstract][Full Text] [Related]
12. DNA methylation: an epigenetic pathway to cancer and a promising target for anticancer therapy.
Worm J; Guldberg P
J Oral Pathol Med; 2002 Sep; 31(8):443-9. PubMed ID: 12220350
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic regulation of microRNA expression in colorectal cancer.
Bandres E; Agirre X; Bitarte N; Ramirez N; Zarate R; Roman-Gomez J; Prosper F; Garcia-Foncillas J
Int J Cancer; 2009 Dec; 125(11):2737-43. PubMed ID: 19521961
[TBL] [Abstract][Full Text] [Related]
14. Reversal of gene silencing as a therapeutic target for cancer--roles for DNA methylation and its interdigitation with chromatin.
Baylin SB
Novartis Found Symp; 2004; 259():226-33; discussion 234-7, 285-8. PubMed ID: 15171257
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic changes in prostate cancer: implication for diagnosis and treatment.
Li LC; Carroll PR; Dahiya R
J Natl Cancer Inst; 2005 Jan; 97(2):103-15. PubMed ID: 15657340
[TBL] [Abstract][Full Text] [Related]
16. [DNA methylation and cancer].
Yoshikawa H
Gan To Kagaku Ryoho; 2007 Feb; 34(2):145-9. PubMed ID: 17301518
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic Silencing of miRNA-34a in Human Cholangiocarcinoma via EZH2 and DNA Methylation: Impact on Regulation of Notch Pathway.
Kwon H; Song K; Han C; Zhang J; Lu L; Chen W; Wu T
Am J Pathol; 2017 Oct; 187(10):2288-2299. PubMed ID: 28923203
[TBL] [Abstract][Full Text] [Related]
18. Gene silencing of MIR22 in acute lymphoblastic leukaemia involves histone modifications independent of promoter DNA methylation.
Li X; Liu J; Zhou R; Huang S; Huang S; Chen XM
Br J Haematol; 2010 Jan; 148(1):69-79. PubMed ID: 19807731
[TBL] [Abstract][Full Text] [Related]
19. A novel epigenetic phenotype associated with the most aggressive pathway of bladder tumor progression.
Vallot C; Stransky N; Bernard-Pierrot I; Hérault A; Zucman-Rossi J; Chapeaublanc E; Vordos D; Laplanche A; Benhamou S; Lebret T; Southgate J; Allory Y; Radvanyi F
J Natl Cancer Inst; 2011 Jan; 103(1):47-60. PubMed ID: 21173382
[TBL] [Abstract][Full Text] [Related]
20. Crosstalk between miRNAs and DNA Methylation in Cancer.
Saviana M; Le P; Micalo L; Del Valle-Morales D; Romano G; Acunzo M; Li H; Nana-Sinkam P
Genes (Basel); 2023 May; 14(5):. PubMed ID: 37239435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
